These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24002503)

  • 1. Insight or confusion: survival after response-guided neoadjuvant chemotherapy in breast cancer.
    Telli ML
    J Clin Oncol; 2013 Oct; 31(29):3613-5. PubMed ID: 24002503
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
    Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response-guided neoadjuvant chemotherapy for breast cancer.
    von Minckwitz G; Blohmer JU; Costa SD; Denkert C; Eidtmann H; Eiermann W; Gerber B; Hanusch C; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Kümmel S; Paepke S; Schneeweiss A; Untch M; Zahm DM; Mehta K; Loibl S
    J Clin Oncol; 2013 Oct; 31(29):3623-30. PubMed ID: 24002511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea?
    Yu KD; Shao ZM
    J Clin Oncol; 2014 Apr; 32(12):1282-3. PubMed ID: 24638014
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for breast cancer: any progress?
    Colleoni M; Goldhirsch A
    Lancet Oncol; 2014 Feb; 15(2):131-2. PubMed ID: 24360786
    [No Abstract]   [Full Text] [Related]  

  • 6. Node micrometastases detection after neoadjuvant chemotherapy in breast cancer: is it of clinical value?
    Ziogas D; Harissis H; Batsis C
    Ann Surg Oncol; 2010 Mar; 17(3):933-4; author reply 935. PubMed ID: 19830493
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neoadjuvant Chemotherapy in breast cancer].
    Suzuki E; Toi M
    Nihon Rinsho; 2006 Mar; 64(3):536-9. PubMed ID: 16529046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy in the treatment of breast cancer.
    Redden MH; Fuhrman GM
    Surg Clin North Am; 2013 Apr; 93(2):493-9. PubMed ID: 23464698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for operable breast cancer.
    Green M; Hortobagyi GN
    Oncology (Williston Park); 2002 Jul; 16(7):871-84, 889; discussion 889-90, 892-4, 897-8. PubMed ID: 12164555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea? Reply to K.-D. Yu et al.
    von Minckwitz G; Loibl S
    J Clin Oncol; 2014 Apr; 32(12):1283-4. PubMed ID: 24638006
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy.
    Bear HD
    Surg Oncol Clin N Am; 2010 Jul; 19(3):607-26. PubMed ID: 20620930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of neoadjuvant therapies in breast cancer with respect to pathological complete response, disease-free survival and overall survival: 15 years follow-up data from Kuwait.
    Krishnan Y; Al Awadi S; Sreedharan PS; Sujith Nair S; Thuruthel S
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e30-7. PubMed ID: 23937427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with breast cancer].
    Tamaki T; Oura S
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():198-201. PubMed ID: 17682157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Certain aspects of neoadjuvant therapy of locally advanced breast cancer].
    Voznyĭ EK; Gurov SN; Dobrovol'skaia NIu
    Vopr Onkol; 2001; 47(6):690-4. PubMed ID: 11826490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Option of the surgical mode for breast cancer based on the effect of neoadjuvant chemotherapy].
    Fukutomi T
    Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):803-5. PubMed ID: 12478855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neoadjuvant systemic chemotherapy for patients with operable breast cancer].
    Zhang B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):161-5. PubMed ID: 17649628
    [No Abstract]   [Full Text] [Related]  

  • 17. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
    Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
    Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis.
    Zhang N; Moran MS; Huo Q; Haffty BG; Yang Q
    Cancer Invest; 2011 Nov; 29(9):594-8. PubMed ID: 22011281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant chemotherapy of patients with breast carcinoma].
    Jakesz R; Taucher S; Gnant M; Gebhard B; Kandioler D; Rudas M; Djavanmard M; Steger G
    Zentralbl Chir; 1998; 123 Suppl 5():147-50. PubMed ID: 10063601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.